Inspire Sleep Apnea Therapy: Who May Qualify and What to Expect

Quick answer: Inspire is an implanted upper-airway stimulation system for selected people with obstructive sleep apnea (OSA) who cannot use or tolerate positive airway pressure (PAP). It is not a general replacement for CPAP and it is not a treatment for every type of apnea. A sleep specialist and surgeon must review your sleep study, PAP history, anatomy, other conditions, and insurance requirements.

How Inspire works

The system detects breathing and delivers small electrical impulses to a nerve that helps move the tongue forward, reducing upper-airway collapse during sleep. A patient remote turns therapy on before sleep and off after waking. Implantation is followed by healing, activation, adjustment, and a sleep study or other assessment to check whether treatment is working. This is a continuing treatment pathway, not a one-time cure.

Who might be considered?

The FDA's Inspire approval summary describes adults age 22 and older with moderate to severe OSA and an apnea-hypopnea index (AHI) from 15 through 100 who meet PAP intolerance or failure criteria. The 2023 labeling expansion raised the AHI ceiling to 100 and the recommended BMI ceiling to 40. Those numbers are screening criteria, not a guarantee of eligibility or insurance coverage. Specific labeling also addresses younger patients, including some with Down syndrome; this article focuses on adult evaluation.

PAP intolerance must be documented according to clinical criteria. A drug-induced sleep endoscopy is commonly used to examine how the airway collapses. The FDA summary says Inspire should not be used when there is complete concentric collapse at the soft palate. A predominance of central or mixed apneas can also exclude a person. A clinician must review implant interactions, pregnancy plans, MRI needs, and other contraindications in the current labeling.

What to try before deciding on surgery

If CPAP is difficult, ask for a structured troubleshooting visit. A different mask style, pressure review, humidification adjustment, or help with leaks may make treatment usable. Other options, depending on your study and preferences, can include a custom oral appliance, positional therapy, and weight management. The AASM surgical referral guideline supports discussing surgery with selected adults who cannot tolerate PAP, within a shared decision process.

Benefits, limits, and questions

The FDA describes reductions in OSA severity and improved quality of life in study populations, but results vary. Surgery brings risks such as pain, infection, discomfort from stimulation, and possible device revision. You will still need follow-up and periodic checks. Ask your care team what improvement is realistic for your AHI and symptoms, which adverse events matter for you, and what happens if the device does not control your apnea adequately.

Bring your recent sleep study, PAP usage data, medication list, and a record of mask or pressure problems to the consultation. Ask whether the implant, facility, anesthesia, and follow-up are covered separately by your insurance. Do not stop current treatment while awaiting evaluation unless your clinician advises it.

Next step

If you have not had a recent diagnosis, discuss testing with a medical provider first. A home sleep apnea test may be appropriate for some uncomplicated adults, while others need an in-lab study. The test and a clinical review establish which treatments are worth discussing.